Pfizer’s got its eye on more than the COVID-19 market By: MarketWatch May 04, 2022 at 14:28 PM EDT The company is already laying the groundwork for what it will look like when revenue from its COVID-19 franchise begins to wane. Read More >> Related Stocks: Biontech Se ADR Moderna Inc Pfizer
